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TAFIIs Mediate Activation of
Transcription in the Drosophila Embryo
Frank Sauer,† David A. Wassarman,*† 1995b). Bicoid is part of a cascade of transcription fac-
tors that controls the formation of a segmented bodyGerald M. Rubin, and Robert Tjian
Howard Hughes Medical Institute plan in the early Drosophila embryo (Ja¨ckle and Sauer,
1993). The bicoid gene (bcd) encodes a homeodomainDepartment of Molecular and Cell Biology
University of California protein that forms an anterior/posterior concentration
gradient in the embryo (Driever and Nu¨sslein-Volhard,Berkeley, California 94720-3204
1988a). Genetic and molecular analyses suggest that
Bicoid initiates the formation of anterior body structures
by selectively activating the transcription of several zy-Summary
gotic segmentation genes (Hoch and Ja¨ckle, 1993). Bi-
coid acts synergistically with another factor, Hunch-Mutations in the genes for two highly conserved TAFs,
back. We described previously an in vitro reconstitutedTAFII60 and TAFII110, reduce transcription of Bicoid-
transcription system responsive to Bicoid and Hunch-dependent target genes in vivo. By means of several
back that allowed us to formulate a molecular mecha-distinct genetic test systems, specific activator–TAF
nism for the transcriptional synergy that is found be-interactions are shown to support both simple and
tween these factors. (Sauer et al., 1995a; 1995b). Directsynergistic enhancement of transcription in the em-
protein-binding assays revealed that the glutamine-richbryo. These studies provide in vivo evidence that TAFs
activation domain of Bicoid contacts TAFII110, one ofcan serve as coactivators to receive gene-specific
the subunits of TFIID. By contrast, the alanine-rich acti-transcriptional activation signals. This genetic system
vation domain of Bicoid, as well as the Hunchback acti-also presents the opportunity to study the function of
vation domain, was found to interact with TAFII60,basal transcription components in regulating develop-
another subunit of TFIID. Multiple and presumably si-ment of complex organisms.
multaneous activation domain–TAF interactions contrib-
ute to synergistic activation of transcription in vitro byIntroduction
enhancing or stabilizing the binding of TFIID to the pro-
moter. These biochemical studies reveal a possible roleMetazoan organisms undergo complex developmental
for TAFs in mediating both simple and synergistic tran-programs that are orchestrated by precise temporal and
scriptional activation of Drosophila genes. However, itspatial patterns of transcription (St. Johnston and Nu¨ss-
remained unknown whether TAFs are also required forlein-Volhard, 1992; Hoch and Ja¨ckle, 1993; De Robertis
transcription in vivo and whether they operate by theseand Sasai, 1996). In vitro studies suggest that activation
same mechanisms in Drosophila.of transcription is governed by the assembly of multipro-
To establish a sensitized genetic system in which totein complexes at the core promoter of eukaryotic genes
screen for potential Drosophila TAF mutants, we have(Tjian and Maniatis, 1994; Roeder, 1996). This process
taken advantage of the unique properties offered byis modulated and enhanced by specialized transcription
transcription and signal transduction pathways that op-factors that bind directly to target genes via sequence-
erate during Drosophila eye development (Wassarmanspecific DNA-binding domains. Once tethered to spe-
et al., 1995). Here, we report the isolation of mutantcific control elements of a gene, appropriately exposed
alleles for TAFII60 and TAFII110 in a genetic screen sensi-activation domains of enhancer-binding proteins are
tive to transcription levels. Characterization of the TAFthought to contact various components of the general
proteins encoded by the mutant alleles reveal that theytranscriptional machinery that include basal factors
fail to become incorporated into TFIID in vivo. Since(TFIIA, TFIIB, TFIID, TFIIE, TFIIF, and TFIIH), RNA poly-
TAFII60 and TAFII110 were found to be targets of Bicoidmerase II, and associated multiprotein cofactors (Ver-
based on previous in vitro experiments, it became feasi-rijzer and Tjian, 1996; Roeder, 1996).
ble to directly test the functional relevance of Bicoid–Many eukaryotic activators have been found to inter-
TAF interactions in mediating activation of transcriptionact with one or more subunits of the essential transcrip-
in the Drosophila embryo. We present evidence thattion factor, TFIID, comprised of the TATA-binding pro-
both TAFII60 and TAFII110 are required for Bicoid-depen-tein (TBP) and some eight different TBP-associated
dent activation of segmentation gene transcription infactors (TAFs) (Verrijzer and Tjian, 1996). Different acti-
vivo. Our results also suggest that TAFs serve as coacti-vators are able to contact distinct TAFs within the TFIID
vators responsible for both simple and synergistic tran-complex to mediate activation of transcription in vitro
scription during development of the Drosophila embryo.(Chen etal., 1994). We previously identified the Drosoph-
ila transcription factor, Bicoid, as an activator that uti-
lizes TAFs to mediate transcriptional activation in recon- Results
stituted transcription reactions (Sauer et al., 1995a;
Isolation of TAFII60 and TAFII110 Alleles
in a Dominant Modifier Screen
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Figure 1. TAFII110 and TAFII60 Alleles Suppress the Rough Eye Phenotype of sev-Ras1V12
(a–e) Scanning electron micrographs of wild type (a), P[sev-Ras1V12]/6 (b), TAFII110S-466/ P[sev-Ras1V12] (c), TAFII110XS-793/P[sev-Ras1V12] (d), and
TAFII60XS-922/P[sev-Ras1V12] (e). Anterior is to the right.
(f and g) Molecular lesions within the TAFII110 and TAFII60. Exons are represented by numbered boxes; introns, by lines. Dots indicate the
location of mutations that are described in more detail in the text. In (f), two TAFII110 alleles, TAFII110XS-793 and TAFII110S-466, were sequenced
and shown to have mutations at the 59 end of exons (6) and (7), respectively. In (g), one TAFII60 allele, TAFII60XS-922, was sequenced and shown
to have a mutation in exon (1).
transforms nonneuronal cone cells into R7 photorecep- the first class of cDNAs predicts a novel protein of 558
amino acids (Zn72D) that contains three zinc finger mo-tor cells (Fortini et al., 1992). These extra R7 cells disrupt
tifs. The secondclass of cDNAs encodesTAFII110, whichthe normal packing of cells in ommatidia, resulting in
had been previously sequenced and cytologicallyan external roughening of the eye (for example, see
mapped to 72D4–5 (Hoey et al., 1993). Sequence analy-Figure 1b). To identify components of the Ras1 signaling
sis revealed that while the Zn72D ORF is unaltered inpathway during R7 cell development, an unbiased ge-
the remaining five SR3-3 alleles,at least two of theallelesnetic screen was conducted in which mutations that
contain lesions in the TAFII110 ORF (Figure 1f).dominantly reduce (suppress) or increase (enhance) the
The EMS-induced allele SR3-3S-466 contains a C-to-Tseverity of the sev-Ras1V12 rough eye phenotype were
transition in the first position of codon 795, creating aisolated (Karim et al., 1996). Genetic interaction studies
stop codon that C-terminally truncates the normally 921suggest that five suppressor groups, SR3-3, SR3-4B,
aa protein. The X-ray-induced allele SR3-3XS-793 containsSR3-5, SR3-7, and SR3-8, function as positive regulators
a 10 bp deletion that creates a frameshift at amino acidof sev transcription (Karim et al., 1996). Suppression of
483. These lesions were confirmed by immunoblots ofthe rough eye phenotype by SR3-3 or SR3-4B alleles is
nuclear extracts prepared from SR3-3S-466 or SR3-3XS-793illustrated in Figure 1.
heterozygous embryos that reveal truncated TAFII110The ability of SR3-3 to suppress sev-Ras1V12 was
proteins of the expected size, approximately 90 kDa andmapped to the left arm of the third chromosome, to
50 kDa, respectively (Figures 2g and 2h). These data
meiotic map position 3-4765. The lethality associated
confirm that SR3-3 corresponds to the TAFII110 gene;with the SR3-3 alleles was uncovered by two indepen-
we therefore renamed this locus TAFII110.dent chromosomal deletions, Df(3L)th102 and Df(3L)st- The SR3-4B group contains seven X-ray-induced al-
e4, but was complemented by two others, Df(3L)brm11 leles. Two have chromosomal inversions that break in
and Df(3L)st4, placing the gene within the polytene inter- the 76C–F region (and may have associated deletions);
val 72D1–10. Df(3L)th102 also suppresses sev-Ras1V12, four have small deletions that place the gene in the
suggesting that SR3-3 alleles are loss-of-function muta- polytene interval 76B6–C; and one, SR3-4BXS-922, has no
tions. One of the six SR3-3 alleles, SR3-3XS-2884, contains cytologically visible rearrangements (F. S., D. A. W.,
an X-ray-induced inversion breakpoint at 72D. Genomic G. M. R., and R. T., unpublished data). The TAFII60 gene
DNA spanning the breakpoint was isolated and used to maps within this region at 76B9–10 (Weinzierl et al.,
screen a Drosophila eye-antennal imaginal disc cDNA 1993). Sequencing of the TAFII60 gene from SR3-4BXS-
library (see Experimental Procedures). Two classes of 922 revealed an in-frame insertion of six base pairs (TAC-
cDNAs were identified, both of which define transcrip- TAC) that encodes two tyrosine residues adjacent to
tion units that are disrupted in SR3-3XS-2884. Conceptual position 207 of the protein (Figure 1g). In addition, SR3-
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Ras1V12 suggested that additional suppressor loci may
correspond to other TAFIIs. In fact, two of the remaining
three suppressor loci (SR3-5 and SR3-8) that genetically
display properties of transcriptional regulators map cy-
tologically to positions of known TAFIIs (Karim et al.,
1996). Studies are underway to establish the identity of
these loci.
Mutations in TAFII60 and TAFII110 reduce transcription
of several, but not all, genes during eye development
(data not shown). These findings provide evidence that
mutating a single TAF does not diminish transcription
in general. Interestingly, quantitation of reporter gene
expression revealed that TAFII110S-466 and TAFII60XS-922
act as stronger suppressors of sev transcription than
TAFII110XS-793 or deletions of TAFII110 or TAFII60. These
results are consistent with the notion that TAFII110S-466
and TAFII60XS-922 act as transdominant-negative inhibi-
tors of transcription.
TAFII60 and TAFII110 Mutant Proteins Fail to Bind
TAFII250 In Vitro and Are Not Assembled
into TFIID Complexes In Vivo
In vitro binding assays were used to determine whether
the mutant TAFII60 and TAFII110 proteins, encoded by
alleles isolated in the genetic screen, are functionally
impaired due to an inability to participate in the normal
range of protein–protein interactions. Epitope-tagged
proteins encoded by TAFII110S-466 (TAFII110DC), TAFII
110XS-793 (TAFII110DB), and TAFII60XS-922 (TAFII60YY) were
produced in baculovirus-infected cells and immunopuri-
fied (see Experimental Procedures). The resulting affinityFigure 2. Mutant TAFs Fail to Bind TAFII250 and to Assemble into
resins were incubated with 35S-methionine-labeled pro-TFIID
teins expressed in vitro or with Sf9 cell extracts con-(a–f) TAFII110 and TAFII60 mutantproteins fail to bind TAFII250. West-
taining TAFII250 protein (Figure 2). Of the four well-char-ern blots (a and e) or autoradiographs (b–d, f) of protein–protein
interaction assays are shown. Immobilized Flag-epitope-tagged acterized TAFII110 binding partners within the initiation
TAFII110, TAFII110DB, or TAFII110DC (a–d) and TAFII60 or TAFII60YY complex [TAFII250, TAFII30a, TAFII150, and the large sub-
(e and f) were incubated with Sf9 cell extracts containing TAFII250 unit of TFIIA (TFIIA-L) (Yokomori et al., 1993; Verrijzer
(a and e) or 35S-methionine-labeled TAFII30a (b), TAFII150 (c), TFIIA-L and Tjian, 1996)], only TAFII150 is retained on beads(d), or TAFII40 (f). Proteins were separated by SDS–PAGE and
saturated with F-TAFII110DC (Figures 2a–2d) or F-TAFIITAFII250 (a and e) was detected by Western blot using a monoclonal
110DB (F. S., D. A. W., G. M. R., and R. T., unpublishedanti-TAFII250 antibody, or radiolabeled proteins (b–d, f) were de-
tected by autoradiography. Lane 1 of each panel contains 25% data). This indicates that sequences within the C-termi-
input. Asterisks on the left of each panel indicate the position of nal 126 amino acids of TAFII110 are required for binding
the full-length protein. of TAFII250, TAFII30a, and TFIIA-L. This region is con-
(g and h) In (g), full-length TAFII110 and TAFII110DC are indicated tained within an evolutionarily conserved domain in
by an arrowhead and an asterisk, respectively.
TAFII110 that comprises the C-terminal one-third of theTAFII110DB and TAFII110DC are stably expressed in vivo but are
protein (Dikstein et al., 1996).not assembled into TFIID. Using an anti-TAFII250 antibody, TFIID
complexes were immunoprecipitated from nuclear extracts pre- TAFII60 has previously been shown to bind TAFII250
pared from heterozygous TAFII110S-466 (a) or TAFII110XS-793 (b) mutant and TAFII40 (Weinzierl et al., 1993). However, affinity
embryos. Lane 1 contains total nuclear extract (extract) that is equal beads saturated with F-TAFII60YY bound only to TAFII40to the amount used for the immunoprecipitation, lane 2 contains
(Figures 4e and 4f). These results suggest that the inser-immunoprecipitated proteins (IP), and lane 3 contains unselected
tion of two tyrosine residues in TAFII60 directly alters theproteins (IP-Supe). Fractionated proteins were probed with a poly-
binding domain for TAFII250 or induces a conformationalclonal anti-TAFII110 antibody. The position of wild-type TAFII110
protein is indicated by arrows, while truncated TAFII110 proteins are change that prevents TAFII250 binding. The mutation in
indicated by arrowheads. TAFII60XS-922 disrupts an evolutionarily conserved region
of the protein (amino acids 195–452; Weinzierl et al.,
1993). These findings suggest that the mutant TAF pro-
teins are impaired in their interactions with TAFII250 andallele that was isolated in a screen for lethal mutations
in the 76B chromosomal region (J. Kennison, personal might therefore not be incorporated into TFIID.
To test this assumption, nuclear extracts were pre-communication). These data confirm that SR3-4B corre-
sponds to the TAFII60 gene; we therefore renamed this pared from embryos heterozygous for TAFII110S-466 or
TAFII110XS-793 mutations. TFIID complexes were immuno-locus TAFII60.







Figure 3. Mutant TAFs Squelch Bicoid-Dependent Activation of hb Transcription In Vitro
(a) Schematic diagram of Bicoid and wild-type or mutant TAFII60 and TAFII110. Boxed areas marked Bicoid or TAFII250 represent the regions
within the TAFs that interact with Bicoid (amino acids 572–684 for TAFII110; 430–668 for TAFII60) and TAFII250 (amino acids 792–912 for
TAFII110; 212–412 for TAFII60), respectively. (Hd) indicates the position of the Bicoid homeodomain; (Q), the glutamine-rich and (A), the alanine-
rich activation domains.
(b–f) In vitro binding properties of Bicoid activation domains and wild-type or mutant TAFs. In vitro translated wild-type (b, e) or mutant TAFs
(c–d, f) were incubated with glutathione beads loaded with either 100 ng of GST alone (b–f, lane 2) or GST fused to the A-rich (b–d, lane 3;
e–f, lane 4), Q-rich (b–d, lane 4; e–f lane 3), or both Bicoid activation domains (b–f, lane 5). Binding, washing, and detections of bound proteins
were carried out as described in Experimental Procedures. Lane 1 (b–f) represents 25 % of the total input material used in each binding
reaction.
(g–k) Effect of wild-type (g and j) or mutant TAFs (h–i, k) on Bicoid-dependent activation of hb transcription in vitro. Nuclear extracts were
programmed with 10 ng of reporter plasmid phb CAT-298 containing three high affinity Bicoid DNA binding sites and a constant amount (25
ng) of Bicoid derivatives containing only the Q-rich (BCDQ, g–h, lanes 1–3) or A-rich (BCDA; j–k, lanes 1–3) activation domains or no activator
(g–k, lane 4). Increasing amounts (g–h, lane 2, 20 ng; lane 3, 50 ng) of immunopurified wild-type or mutant TAFs were added as indicated in
the top panel. Reaction products were detected as described in Experimental Procedures.
antibody, and selected (pellet) or unselected (superna- mutant TAFs identified in the genetic screen indeed af-
fect Bicoid-dependent activation of transcription intant) proteins were probed with a polyclonal a-TAFII110
antibody (Figures 2g and 2h). Both mutant TAFII110 pro- vitro. First, we tested the ability of the mutant TAF pro-
teins (Figure 3a) to interact with the activation domainsteins were expressed at levels comparable to the wild-
type protein (Figures 2g and 2h, lane 1). However, unlike of Bicoid. In vitro protein–protein interaction assays re-
vealed that, like their wild-type counterparts, TAFII110DCwild-type TAFII110, they werefound predominantly in the
unselected fraction, reflecting their inability to assemble and TAFII60YY are able to interact with the Q-rich (Fig-
ures 3b and 3c, lanes 4–5) or A-rich activation domainsinto stable TFIID complexes (Figures 2g and 2h; com-
pare lane 2 with lane 3). Mechanistically, the same situa- (Figures 3e and 3f, lanes 4–5) of Bicoid, respectively. In
contrast, TAFII110DB failed to interact with either Bicoidtion may occur with TAFII60YY; however, it is technically
difficult to analyze the in vivo binding properties of TAFII activation domain, as it does not contain the region of
the protein (amino acids 572–679; F. S., unpublished60YY since it is the same molecular size as the wild-
type TAFII60 protein. These findings suggest that at least data) required for contacting Bicoid (Figure 3c). These
results, taken together with our TAF–TAF binding stud-TAFII110DC and TAFII110DB are not stable components
of TFIID in vivo. ies, suggest that TAFII110DC and TAFII60YY should be-
have as transdominant-negative inhibitors that can
squelch Bicoid-dependent activation of transcription.Mutant TAFs Squelch Bicoid-Dependent
Activation of Transcription In Vitro To test this prediction, we determined the effect of
these mutant TAFs on Bicoid-dependent activation inBefore addressing the physiological relevance of TAF–
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contained the enhancer/promoter region of the endoge-
nous Bicoid target gene hb fused to a reporter gene
encoding Chloramphenicol-acetyl-transferase. Trun-
cated versions of Bicoid bearing either the Q-rich or
A-rich activation domains were used as activators
(Sauer et al., 1995b). Primer extension was used to de-
tect transcription products in reactions supplemented
with exogenous affinity-purified wild-type or mutant
TAFs. As expected, reactions supplemented with either
the Q-rich (Figures 3g–3i) or A-rich activator (Figures
3j and 3k) directed high levels of transcription. These
activated levels of transcription were only slightly re-
duced in the presence of increasing amounts of wild-
type TAFII110 or TAFII60 (Figures 3g and 3j, lanes 2 and
3). By contrast, increasing amounts of TAFII110DC or
TAFII60YY essentially abolished Bicoid-dependent acti-
vation of transcription (Figures 3h and 3k, lanes 2 and
3). As expected, mutant TAFII110DB, which is unable to
interact with Bicoid, was also unable to squelch tran-
scriptional activation in vitro (Figure 3i). These results
suggest that mutant versions of TAFII110 and TAFII60
that fail to incorporate into the TFIID complex but retain
the ability to interact with Bicoid can inhibit Bicoid-
dependent activation of transcription by sequestering
specific activator proteins in nonproductive complexes.
Figure 4. Effect of Mutations in TAFII60 and TAFII110 on Bicoid Con-Bicoid Expression Is Not Affected by Mutations
centration in Early Drosophila Embryosin TAFII60 or TAFII110
Cellularized wild-type (a) or heterozygous mutant embryos forBefore testing the effects of TAF mutations on transcrip-
TAFII110 (b and c) or TAFII60 (d) were stained using polyclonal Bicoidtion, it was important to first ascertain that flies carrying
antibody (a generous gift of P. Beaurang).
mutant TAFs express normal levels of the activator Bi-
coid. If so, changes in Bicoid-dependent target gene
transcription can be attributed to defects in the coacti- hunchback (hb; Tautz and Pfeifle, 1989) and huckebein
vator function of TAFs. To assess the pattern of Bicoid, (hkb; Bro¨nner et al., 1994). hb is transcribed in a broad
embryos derived from heterozygous mothers containing anterior domain, as well as in a more restricted posterior
wild-type and mutant alleles of TAFII110 or TAFII60 were domain (Figure 5a), while hkb is expressed in small re-
stained with a polyclonal Bicoid antibody. Wild-type and gions localized to the anterior and posterior ends of
heterozygous mutant embryosexpressed Bicoid protein the blastoderm (Figure 5f). Genetic and molecular data
to comparable levels with indistinguishable patterns of suggest that transcription of the anterior hb domain is
staining in the anterior regions of the embryo (Figure 4). activated by a synergistic interplay between Bicoid and
The same result was obtained when bcd mRNA was the transcription factor encoded by hb (Hunchback;
measured in these embryos by insitu hybridization (F. S., Simpson-Brose et al., 1994), whereas transcription of
D. A. W., and R. T., unpublished data). Thus, bcd tran- the anterior hkb domain depends largely on Bicoid. The
scription and expression is apparently not affected by transcription of the posterior hb domain is activated by
the presence of mutant TAFII60 and TAFII110. This result Tailless (Margolis et al., 1995) and is at least partially
was further supported by inspecting the position of the Bicoid-dependent (H. Ja¨ckle, personal communication).
head fold in early embryos. The head fold forms at stage In contrast, the transcription of theposterior hkb domain
7, and its position critically depends on Bicoid concen- is activated by an unknown transcription factor and is
trations (Driever and Nu¨sslein-Volhard, 1988b). Exami- not thought to be dependent on Bicoid (Bro¨nner et al.,
nation of TAFII60 and TAFII110 mutant embryos revealed 1994). We previously established that in vitro, two of
that the location of the head furrow is not altered (F. S., the four transcription factors required for hb and hkb
D. A. W., and R. T., unpublished data). These results transcription (i.e., Bicoid and Hunchback) mediate acti-
provide evidence that bcd transcription and Bicoid con- vation via an interaction with TAFII60 and TAFII110 (Sauer
centration are not adversely affected by mutations in et al., 1995a).
TAFII60 or TAFII110. To assess the effects of mutant TAFs on activated
transcription in vivo, we examined hb and hkb transcrip-
tion in embryos that contained one wild-type and oneTAFII60YY and TAFII110DC Inhibit
Bicoid-Dependent Activation transdominant-negative mutant copy of a TAF. These
test embryos contained either two (F. S., D. A. W., andof hb and hkb Transcription
In the Drosophila embryo, Bicoid activates the transcrip- R. T., unpublished data) or only a single copy of the
target gene (Figure 5). For the sake of simplicity, em-tion of several zygotic segmentation genes (Simpson-








Figure 5. Effect of TAF Mutations on hunch-
back and huckebein Transcription In Vivo
hb (a–e) or hkb (f–j) mRNA was visualized by
in situ hybridization in embryos containing a
single copy of hb (a–e) or hkb (f–j) and hetero-
zygous for mutant TAFII110 (b and c, g and
h), TAFII60 (d and i), or TAFII30a (e and j). Ori-
entation of the stadium 4–5 embryos is as
described in Figure 4.
unit (i.e., hb or hkb) but carrying two wild-type copies 5e and 5j). We repeated these experiments with embryos
containing deletions of TAFII60 and TAFII110 instead ofof the TAFs will be referred to as “wild-type” embryos.
the transdominant-negative alleles. As might be ex-In situ hybridization with hb or hkb DNA probes were
pected, hb and hkb transcription were reduced in theseemployed to detect transcription of the target genes.
embryos,but not to thesame extent of inhibition as in theCompared to wild-type embryos, transcription within
presence of the transdominant-negative alleles (F. S.,the anterior and posterior hb domains was significantly
D. A. W., and R. T., unpublished data). One possiblereduced in heterozygous embryos expressing the trans-
explanation is that in the case of the deletions the assaydominant-negative version of TAFII110 (TAFII110DC; Fig-
system detects a dosage affect that is partly compen-ure 5b). This mutant TAF is unable to incorporate into
sated by maternally contributed wild-type TAFs in theTFIID but retains its coactivator domain and therefore
early embryo. However, in the presence of the transdom-can bind and squelch the activator. By contrast, a TAF
inant-negative TAFs, the level of activation is more se-mutant that isunable to interact and interfere with Bicoid
verely impaired by theability of these proteins to activelyactivation in vitro (TAFII110DB) had no measurable effect
squelch the function of the activator.on hb transcription in the embryo (Figure 5c). Similar
In embryos containing transdominant-negative TAFII60results were obtained with hkb; in heterozygous em-
or TAFII110 alleles, transcription of the posterior hb do-bryos carrying one copy of TAFII110DC, the transcription
main is strongly reduced (Figures 5b and 5d). Theseof the anterior, Bicoid-dependent hkb domain was re-
results suggest that like Bicoid, the acidic-class activa-duced (Figure 5g). In contrast, transcriptionof the poste-
tor Tailless might also require TAFII110 and TAFII60 inrior hkb domain was not detectably reduced, indicating
order to activate hb transcription invivo. This hypothesis
that activation of transcription is not generally impaired
is supported by the observation that at least some
in these embryos. Again, TAFII110DB had no significant acidic-rich activators are able to target TAFII60 in ordereffect on hkb transcription (Figure 5h). Similar results to activate transcription in vitro (Verrijzer and Tjian,
were obtained with embryos containing two copies of 1996). Further, we noted that the transcription of the
the target genes (F. S., D. A. W., G. M. R., and R. T., anterior hb domain is more severely reduced in embryos
unpublished data). Next, we tested the effect of muta- containing TAFII60YY versus TAFII110DC(Figures 5b, 5d,
tions in TAFII60, which can also serve as a target for 5g, and 5i). This result is consistent with the in vitro
mediating transcriptional activation by Bicoid based on finding that TAFII60 directs not only Bicoid but also
our previous in vitro studies. As expected, transcription Hunchback activation of transcription. In further support
of both hb domains and the anterior hkb domain was of this notion, larvae developed from TAFII60 mutant
markedly depressed by the presence of TAFII60YY (Fig- embryos (TAFII60YY, hbD/1,1) display a weak hb and
ures 5d and 5i). Not surprisingly, hb and hkb transcrip- tailless phenotype (F. S., D. A. W., G. M. R., and R. T.,
tion were not affected in the presence of a mutant form unpublished data). These results suggest that mutants
of TAFII30a (TAFII30a-z; F. S., D. A. W., G. M. R., and of TAFII60 and TAFII110 that retain Bicoid binding activity
R. T., unpublished data) that has not been found to but fail to incorporate into TFIID can squelch the tran-
interact with Bicoid and is not required for Bicoid- scription of Bicoid-dependent target genes in the Dro-
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Figure 6. Effect of Wild-Type and Mutant TAFII110 Expressed under the Control of the bicoid Transcription Unit
(a) Schematic representation of P-element plasmids containing the bcd transcription unit expressing wild-type or mutant forms of TAFII110.
The start site of transcription within the bcd promoter is marked by an arrow. (HA) indicates the position of the hemaglutinin epitope tag, and
(bcd 39UTR) demarcates the bcd 3-prime untranslated region. The domains of TAFII110 contacted by Bicoid or TAFII250 are highlighted.
(b) Immunostaining of Bicoid in wild-type embryos using polyclonal Bicoid antibody.
(c–e) P element–derived TAFs (P-TAF) were detected in embryos derived from mothers containing two copies of the P elements expressing
TAFII110 (c), TAFII110DC (d), or TAFII110DB (e) using monoclonal HA antibody.
(f–m) Effect of P-TAFs on hb (f–i) and hkb (j–m) transcription in embryos containing a single copy of these Bicoid target genes. “Wild-type”
embryos (f and j), embryos containing two copies of P-element plasmids expressing wild-type TAFII110 (g and k), TAFII110DC (h and l), and
TAFII110DB (i and m) were stained using hb (f–i) or hkb (j–m) cDNA probes. The orientation of the stadium 5 embryos is anterior left, dorsal up.
lacking the coactivator domain (i.e., TAFII110DB) re- In order to bypass the possibility of TAF mutations
affecting transcription of important maternal genes, wequired for interaction with Bicoid, as well as other TAFs
that are not targeted by Bicoid in vitro, have no signifi- generated flies that synthesized mutant TAFs in the em-
bryo, but not in maternal cells. We achieved this bycant influence on Bicoid-dependent activation of tran-
scription in vivo. These results confirm a role for TAFII60 employing the same strategy used by the female fly to
express Bicoid exclusively in the oocyte. We con-and TAFII110 in theactivation of segmentation gene tran-
scription in the Drosophila embryo. structed P-element plasmids containing epitope-tagged
cDNAs encoding wild-type and mutant TAFII110 that
were attached to a transcription unit comprised of theMaternally Derived Mutant TAFs Targeted to the
Embryo Squelch Bicoid-Dependent Activation bcd enhancer/promoter and the bcd 39 untranslated re-
gion (39UTR) (Driever et al., 1990). The bcd enhancer/Although we observed that transcription of the maternal
bcd gene is not affected by TAFII60 and TAFII110 muta- promoter directs the transcription of mutant TAFs in the
maternal nurse cells during oogenesis. The bcd 39UTRtions (Figure 4), we cannot exclude the possibility that
they affect transcription of other maternal genes whose mediates the transport and localization of TAF mRNA
into the prospective anterior pole of the oocyte, whereproducts are essential for Bicoid-dependent activation
of hb and hkb transcription in the embryo. Suchmaternal TAF and endogenous bcd mRNAare cotranslatedduring
early embryogenesis. These constructs were insertedeffects could contribute to the transcriptional defects
observed above, especially since the embryos we used into the fly genome by P element–mediated transforma-
tion. Antibody staining using a monoclonal antibody di-in the previous experiments were derived from heterozy-
gous mutant mothers. This issue was a concern because rected against the epitope tag of the P element–derived
TAFs (P-TAF) revealed that they, like Bicoid (Figure 6b),it becameobvious that TAF mutationshave a substantial
effect on hb and hkb transcription and that the trans- form an anterior/posterior concentration gradient in the
anterior half in embryos derived from mothers con-dominant TAFs reduce transcription in heterozygous








Figure 7. Fusion Activators Are Expressed
and Activate Transcription in the Bolwig
Organ
(a) Schematic diagram of effector (upper
panel) and reporter (lower panel) P-element
constructs used in the genetic test system
for determining the functional relationship of
TAF–activator interactions in vivo. The ef-
fector plasmid contains five copies of a DNA
binding site for the Drosophila transcription
factor GLASS, linked to the heat-shock pro-
moter directing the expression of hybrid
Gal4-Bicoid proteins comprised of the DNA
binding domain (DBD, amino acids 1–147) of
the yeast activator Gal4 alone or fused to the
glutamine-rich (Q), alanine-rich (A), or both
activation domains of Bicoid. The reporter
gene contains five copies of the Gal4 DNA
binding site upstream of the core-promoter
region of the Drosophila sevenless gene posi-
tioned to direct the expression of lacZ.
(b–e) Expression of the fusion activators in
the Bolwig organ detected by immunostain-
ing using a polyclonal antibody directed
against the Gal4 DNA binding domain.
(f–i) Fusionactivator dependent reporter gene
transcription in the Bolwig organ. Embryos
containing P elements for both the effector
and reporter constructs were assayed using
a lacZ DNA probe. Dorsal of the stage 13 and
14 embryos is up, anterior left.
The presence of additional P-TAFII110 did not affect above suggested that both TAFII60 and TAFII110 are
likely targets for Bicoid-dependent activation of tran-the transcription of either of the target genes (Figures 6g
and 6k). In contrast, hb transcription, as well as anterior, scription. However, our in vivo studies thus far provide
no evidence for discriminating which activation domainsBicoid-dependent hkb transcription, becomes signifi-
cantly reduced in the presence of P-TAFII110DC (Figures of Bicoid contact which specificTAFs in order to activate
transcription.6h and 6l), but not of P-TAFII110DB (Figures 6i and 6m).
These results suggest that a reduction in Bicoid-medi- To address this issue, we devised an in vivo assay
system comprised of an effector gene and a reporterated activation of hb and hkb transcription in the pres-
ence of mutantTAFII110 is not due todisruption of Bicoid gene that allows us to directly test the functional rele-
vance of select TAF/activator interactions in the Dro-localization or concentration. These experiments also
help rule out maternal effects that may contribute to the sophila embryo. The effector gene was designed to ex-
press fusion activators under the control of the basalobserved reduction of Bicoid-dependent activation in
the embryo. Instead, these findings confirm that activa- heat-shock promoter fused to an enhancer recognized
by the Drosophila transcription factor, Glass, which di-tion of transcription by Bicoid requires TAFII110, most
likely as a coactivator subunit of TFIID, to mediate tran- rects cell type–specific expression in the Bolwig organ,
a larval light sensor formed during later stages of em-scription of natural target genes in vivo.
bryogenesis (Moses and Rubin, 1991). We constructed
four different test activators, each consisting of the DNADifferent Activation Domains Require Distinct
binding domain of the yeastactivator Gal4 alone or fusedTAFs to Mediate Transcription
either to the Q-rich, A-rich, or both activator domainsThe coactivator model of transcriptional activation pro-
of Bicoid (Figure 7a). The reporter construct containedposes that for certain activators, direct contact between
five Gal4 DNA binding sites linked to the promoter ofan activation domain and a specific TAF subunit of TFIID
the Drosophila sevenless gene driving the transcriptionis at least in part responsible for mediating activation
of lacZ (Figure 7a).of transcription (Verrijzer and Tjian, 1996). Our previous
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presence of the Q-rich activator, suggesting that the
strong Q-rich activation domain of Bicoid requires
TAFII110 to mediate activation of transcription in vivo
(Figure 8c). In contrast, the weaker A-rich domain activa-
tor remains active even in the presence of TAFII110DC,
indicating that transcriptional activation is not generally
impaired in these embryos (Figure 8d). The reciprocal
result was obtained in homozygous TAFII60YY mutant
embryos: the Q-rich transcription factor supported acti-
vation of the reporter gene (Figure 8g), while the A-rich
activator failed to enhance transcription (Figure 8h).
Thus, in agreement with previously reported in vitro
studies (Sauer et al., 1995b), the two different Bicoid
activation domains requiredistinct TAFs to mediateacti-
vation of transcription in the Drosophila embryo.
Our in vitro studies also suggested a TAF-mediated
mechanism for Bicoid-dependent synergistic activation
of transcription (Sauer et al., 1995b). To test the TAF
requirements for synergy in vivo, we used a fusion acti-
vator containing both the Q-rich and A-rich Bicoid acti-
vation domains. As expected, this bipartite activator di-
rects a high level of reporter-gene transcription in the
Bolwig organ of wild-type embryos (Figure 9e). In con-
trast, the level of activation was significantly reduced,
but not eliminated, in TAFII110 homozygous mutant em-
bryos (Figure 9f). A similar result was observed for the
TAFII60 mutant (Figure 9g). However, in double-homozy-
gous TAF mutant embryos the QA-rich activator essen-
tially gave undetectable levels of reporter-gene tran-
Figure 8. Different Activation Domains Require Distinct TAFs to Ac- scription (Figure 9h). To obtain a more quantitative
tivate Transcription In Vivo measure of synergy, we used a b-galactosidase sand-
(a–d) The Q-rich Bicoid activation–domain requires TAFII110 in order wich ELISA assay to measure reporter-gene expression
to activate transcription in vivo. Homozygous mutant embryos for in vivo. In the presence of either one or the other trans-
TAFII110 (a–d) or TAFII60 (e–h) containing P elements for the effector dominant mutant TAFs targeted by the Gal4-QA activa-and reporter genes described in Figure 7 were stained with poly-
tor, reporter-gene transcription was activated approxi-clonal Gal4 antibody (a and b, e–f) or lacZ DNA (c–d, g–h). The Q-rich
mately 3-fold. By contrast, when both TAFII60 and(a and e) or the A-rich (b and f) fusion activators were expressed at
comparable levels in the Bolwig organ of homozygous TAF mutant TAFII110 are wild-type, a large enhancement of reporter-
embryos. For orientation of the stadium 12–14 embryos, see gene expression (17-fold) was observed (Figure 9i).
Figure 7. These experiments, by in large, recapitulate the results
that were observed in vitro where the fusion activator
supports weak activation in the presence of only one of
of the four different fusion activators in the transgenic the coactivator targets but greater than additive levels
embryos by staining with polyclonal anti-Gal4 antibody of activation when both targets are present. Thus, the
(Figures 7b–7e). In situ hybridization with a lacZ probe simultaneous interactions of two different Bicoid activa-
was used to detect transcription of the reporter gene. tion domains with distinct TAFs in the TFIID complex
As expected, of the four activators, only the control contributes to the synergistic activation of transcription
Gal4DBD failed to activate transcription of the reporter in vivo. Our results provide evidence that TAF–activator
gene in the Bolwig organ, although the A-rich activator interactions play a role in both simple and synergistic
was somewhat weaker than the others (Figures 7f–7i). activation of transcription in the Drosophila embryo.
We previously established that in vitro, the Q-rich activa-
tion domain of Bicoid targets TAFII110, while the A-rich
activation domain contacts TAFII60 in order to activate Discussion
transcription (Sauer et al., 1995b). Here, we have at-
tempted to determine the importance of specific activa- TFIID is required to reconstitute activator-dependent
transcription by RNA polymerase II for many promoterstor coactivator interactions in vivoby assaying transcrip-
tion in embryos homozygous for mutant TAFII60 or in vitro (Dynlacht et al., 1991). Holo-TFIID isolated from
eukaryotic cells is a multiprotein complex comprised ofTAFII110. In order to minimize the effects of mater-
nal wild-type TAFs present in the embryo, we used the TATA-binding protein decorated with a host of TAF
subunits ( Verrijzer and Tjian, 1996; Roeder, 1996). It hastransdominant-negative TAF alleles, TAFII110DC and
TAFII60YY. been proposed that eukaryotic organisms have evolved
various classes of gene-specific activators that contactIn embryos homozygous for mutant TAFII110DC, both
fusion activators were expressed to comparable levels one or more TAFs in the TFIID complex in order to medi-
ate transcription of their target genes. Our study extendsin the Bolwig organ (Figures 8a and 8b). However, re-








Figure 9. Multiple TAF–Activator Interactions Support Synergistic Activation of Transcription In Vivo
(a–h) Embryos containing the reporter and an effector gene expressing a fusion activator containing both the Q- and A-rich Bicoid activation
domains were stained with polyclonal Gal4 antibody (a–d) or lacZ DNA (e–h). The activator was expressed at similar levels in the Bolwig organ
of wild-type (a), TAFII60 (b), TAFII110 (c), or double homozygous mutant embryos (d).
(i) Quantitative measurements of reporter gene expression. Total cell extracts were prepared from wild-type or homozygous mutant embryos
for TAFII60, TAFII110, or both. The levels of b-galactosidase present in 1 mg of embryo extract were measured using a sandwich ELISA assay
system. The extracts were standardized based on their relative fusion activator concentrations detected using an ELISA assay. Each bar
represents the mean of at least 10 different experiments using 5 distinct extracts. Standard deviations are indicated by bars.
TAFs are also required for activation of transcription in suggest that Bicoid uses the same targets within TFIID
to activate the transcription of distinct genes, i.e., hbvivo. Two highly conserved subunits of TFIID, TAFII60
and TAFII110, are required for Bicoid-dependent tran- and hkb. This conclusion is further supported by the
observation that Bicoid-dependent activation of twoscriptional activation of cognate target genes in the Dro-
sophila embryo. We have shown that two distinct activa- other target genes, buttonhead and tailless (Ja¨ckle and
Sauer, 1993), is also reduced in TAFII60 and TAFII110tion domains (glutamine-rich and alanine-rich) present
in eukaryotic activators require TAFII110 and TAFII60, mutant embryos (F. S., D. A. W., and R. T., unpublished
data). However, we cannot exclude the possibility thatrespectively, in order to mediate transcription.
the activation of some Bicoid target genes involves con-
tact between the activator and other TAFs, or betweenThe Role of TAFs in Mediating Activation
as yet unidentified coactivators and additional compo-of Segmentation Gene Transcription
nents of the preinitiation complex.Bicoid is required for the activation of at least ten differ-
ent zygotic segmentation genes (Hoch and Ja¨ckle,
1993). Here, we report that Bicoid utilizes TAFII60 and Differences between Drosophila and Yeast?
The general transcriptional machinery and the preinitia-TAFII110 as coactivators to regulate the transcription of
two of its target genes, hunchback (hb) and huckebein tion complex are comprised of at least fifty different
polypeptides, each of which may be a potential target(hkb). Our results indicate that mutations in TAFII60 and
TAFII110 affect the levels of hb transcription in the early for gene-specific activators to regulate transcription ini-
tiation (Tjian and Maniatis, 1994; Verrijzer and Tjian,embryo. In addition, these TAF mutations impede the
anterior, Bicoid-dependent transcription of hkb, while 1996; Roeder, 1996). Given the functional similarities
between the eukaryotic basal-transcriptional machineryhaving little or no effect on posterior, Bicoid-indepen-
dent transcription. It remains possible that other TAFs and sigma factors in prokaryotes it should not be sur-
prising to find that activatorsmay target multiple compo-and/or coactivators are required for transcription of hkb
in the posterior region of the embryo. These findings nents of the preinitiation complex. For example, in addi-
tion to TAFs, activators have been shown to interact inprovide strong support for a mechanism in which indi-
vidual TAFs may be required for the transcriptional acti- vitro with several other components of the preinitiation
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In many cases, the functional relevance of specific acti- entirely excluded, there is at present no evidence to
support this intriguing but speculative scenario.vator interactions with components of the preinitiation
complex have not been decisively established. By con- It is also possible, however, that there are significant
differences between the function of TAFs in yeast and intrast, the role of TAFs and TFIID in mediating transcrip-
tional activation has been amply documented by a pleth- metazoans. For example, it has been generally observed
that yeast do not contain a large variety of differentora of in vitro reconstituted transcription reactions
(Verrijzer and Tjian, 1996). However, the majorityof these activator classes. Instead, most, if not all, activators that
have been characterized from yeast fall into the acidicexperiments have been carried out in vitro with isolated
polypeptides or highly purified transcription reactions class (Ptashne, 1988). Bycontrast, the expanding collec-
tion of activators that have been characterized fromand leave open the possibility that activities and transac-
tions detected in cell-free systems may not reflect the Drosophila and mammals includes a large variety of
distinct classes, such as glutamine-rich, alanine-rich,in vivo situation.
Indeed, recent experiments performed in yeast have isoleucine-rich, proline-rich, and acidic (Tjian and Ma-
niatis, 1994). More importantly, with the exception ofbeen interpreted to indicate that TAFs are not generally
required for transcriptional activation (Moqtaderi et al., the acidic class, many of these metazoan activators
failed to function when introduced into yeast, sug-1996; Walker et al., 1996). Thus, it was possible that
experiments establishing the role of TAFs in vitro did gesting that the transcriptional machinery in flies and
man may have evolved additional essential componentsnot accurately reflect their function in vivo. However,
it is also possible that apparent differences observed to accommodate the increased complexity of gene ex-
pression in multicellular organisms.between the role of TAFs in yeast and Drosophila reflect
inherent limitations in the experimental strategy that was Perhaps a more limited subset of genes requires TAFs
for transcription in yeast, whereas in organisms such asadopted. First, there was no evidence in vitro that the
activators chosen for the studies in yeast are able to Drosophila and man, the complexity of developmental,
tissue-specific, and stimulus-response cascades ofbind specific TAFs or require TAFs for mediating tran-
scriptional activation. Thus, in our view, it is probable gene expression demand a more elaborate transcrip-
tional machinery that is highly dependent on TAFs asthat the correct TAF–activator pairs have not been
tested. Therefore, eliminating a specific TAF or even a coactivators. Indeed, integral subunits of TFIID, such as
Drosophila TAFII110 and human TAFII130, have not beenset of TAFs in yeast is not expected to have an effect
on transcription of randomly selected genes. Given the found in yeast (Reese et al., 1994; Poon et al., 1995).
These findings may also help to explain why glutamine-fact that all experiments, both in vitro and in vivo carried
out to date, indicate that TAFs function in a gene-spe- rich activators failed to function in yeast. Moreover, the
recent discovery of a cell-type specific TAF related tocific manner, choosing the appropriate activator–TAF
pair becomes critical to analyzing the potential coactiva- TAFII130 in humans implies even greater degrees of
combinational specificity in the coactivatorcomponentstor function of these TFIID subunits. Thus, it should be
possible to identify specific yeast genes and activators of the preinitiation complex (Dikstein et al., 1996).
that are dependent on TAFs for transcription.
The in vivo studies reported here reveal that in Dro- A Genetic System for Identifying
sophila, mutation of even a single TAF is sufficient to Components of the RNA Pol II
down-regulate transcription of specific genes duringde- Transcriptional Machinery
velopment. By contrast, reduction or elimination of indi- Mutations in TAFII60, TAFII110, and possibly other tran-
vidual TAFs in yeast had no significant effect on tran- scription factors were isolated as positive regulators
scription of several test genes. Despite the obvious of sev transcription because the rough eye phenotype
differences between Drosophila and yeast, it is interest- caused by Ras1V12 is dose-sensitive (Karim et al., 1996).
ing that mutations in TAFs are lethal in both organisms A small change in the level of Ras1V12 expression is
(Verrijzer et al., 1994; Reese et al., 1994; Poon et al., reflected by a visible change in the external morphology
1995). Moreover, in both yeast and mammalian cells, of the adult eye. It is interesting to note that although
certain TAF mutant alleles lead to specific cell-cycle the sev-Ras1V12 screen was highly sensitive and unbi-
arrest phenotypes (Wang and Tjian, 1994; Apone et al., ased, and a relatively large number of flies was scored
1996). For example, a mutation in human TAFII250 was (z850,000), not all of the known TAFIIs could be mutatedshown to affect the transcriptional activity of specific to a detectable phenotype. One possibility is that only a
genes critical to cell-cycle progression, such as cyclin
subset of TAFIIs is required to activate sev transcription,A, but not other genes (c-Fos) or global transcription
supporting the proposal that TAFIIs do not play a generalrates (Wang and Tjian, 1994). Thus, the most parsimoni-
role in transcriptional activation (Tjian and Maniatis,
ous interpretation would be to conclude that some TAFs
1994).
are required to mediate transcriptional activation of se-
lect cell-cycle genes. Perhaps transcription of essential
Phenotypes of TAF Mutantscell-cycle regulatory genes, such as the cyclins, are gov-
Maternal expression of TAFII60 and TAFII110 appears toerned by a subset of transcriptional activators that re-
be required for oogenesis, as well as for cell proliferationquire TAFs in both mammals and yeast. However, it has
and/or survival, since homozygous germline clones ofalso been proposed that in yeast, temperature sensitive
mutant TAF alleles generated using the ovoD mutationmutations in TAF subunits do not affect transcription
in the FLP-FDS system failed toproduce eggs,and sincebut instead directly regulate the cell cycle (Apone et al.,







AccI or 290 bp NdeI–AccI bcd cDNA fragments encoding the Q, A,using the FLP-FRT system were not recovered (D. A. W.,
orboth Bicoid activation domains into pBGal4DBD (Ma andPtashne,unpublished data). These results are consistent with the
1987). The fusion genes were inserted as BglII–BamHI fragmentsobservation that TAFIIs are required for viability in yeast.
into the BglII restriction site of the P-element vector pGMR-1, con-
Embryos homozygous for TAFII60XS-922, TAFII110S-466, or taining five tandem DNA binding sites for Drosophila Glass in front of
TAFII110XS-793 alleles die at stage 15–16 of embryogenesis the hs promoter (Moses and Rubin, 1991) to generate pCaSpeRhs-
Gal4A, pCaSpeRhs-Gal4Q, or pCaSpeRhs-Gal4QA. The P-elementbut appear to develop normally up to this stage and
plasmid pCaSpeR-5UAS-sevlacZ was constructed by inserting adevelop a normal Bolwig organ (D. A. W., unpublished
105 bp PstI–NdeI DNA fragment, comprised of five multimerizeddata; see Figures 7–9). This is probably due to a large
Gal4 DNA binding sites (UAS) (Goodrich et al., 1993) into pBluescriptmaternal contribution of wild-type TAFs that provide
to generate pB5UAS. The five UAS were cloned as an EcoRI–NotI
sufficient function throughout stage 16. Consistent with fragment together with a 1053 bp NotI–KpnI fragment encoding the
this hypothesis, we observed that transgenically derived sevenless promoter (Bowtell et al., 1989) into the corresponding
restriction sites of pCaSpeRhs43-bGal (Thummel and Pirotta, 1992)TAFII110-dependent activators retained the ability to di-
to generate pCaSpeR-5UAS-sevlacZ.rect very weak transcription of reporter genes in the
Bolwig organ, even when both copies of TAFII110 were
In Vitro Transcriptiondeleted in mutant embryos (F. S., D. A. W., G. M. R.,
In vitro transcription was carried out essentially as described (Sauerand R. T., unpublished data).
et al., 1995b), except that Drosophila nuclear extract was used (Big-
Although our results indicate that hb and hkb tran- gin and Tjian, 1988). Nuclear extract, activator, reporter plasmid,
scription is depressed in mutant embryos, we did not and, if present, TAFs were preincubated for 15 min. at 208C, and
observe severe segmentation phenotypes in the mutant transcription was initiated by the addition of rNTPs. Activators and
mutant and wild-type TAFs were expressed and purified as de-embryos. It is likely that the reduced transcription levels
scribed. Reactions products were measured using primer extensionnevertheless provide sufficient hkb and hb expression
and detected by autoradiography as described previously (Sauerfor proper segmentation. We note that the levels of hb
et al., 1995b).
and hkb protein are not reduced to the same extent as
the levels of mRNA (F. S., D. A. W., G. M. R., and R. T.,
ELISA
unpublished data). Apparently, there is some mecha- Cell extracts from 500 mg embryos were prepared as described
nism for partly compensating the reduced levels of tran- by Biggin and Tjian (1988). A sandwich ELISA designed to detect
scription. In contrast to the reduced levels of transcrip- b-galactosidase (59Prime-39Prime, Boulder, USA) in cell extracts
was used according to the instructions of the manufacturer. Gal4tion, the spatially restricted patterns of target-gene
fusion proteins were detected using an ELISA system. The amountstranscription were not substantially altered by TAF mu-
of cell extracts used in the b-galactosidase test were standardizedtations. These results are consistent with the notion that
based on the amount of fusion activator present.
the levels of transcription in a given Drosophila segment
may be dictated by activators such as Bicoid, but the
Protein Binding Assays
boundaries of spatially restricted domains of expression Generation of recombinant baculovirus and expression and purifica-
also require repressors and other regulators (Hoch and tion of epitope-tagged proteins from Sf9 cells infected with recombi-
nant baculovirus or GST-proteins from E. coli were performed asJa¨ckle, 1993).
recently described (Sauer et al., 1995a; 1995b). For protein binding
assays, 50 ng of GST or GST-Bicoid fusion proteins were immobi-
Experimental Procedures lized on glutathione beads incubated with labeled TAFs. Protein
binding reactions contained 50 ng of Flag-epitope-tagged TAFII
Plasmids or GST-proteins immobilized on Flag–M2 antibody resin (Eastman
Baculovirus plasmids expressing mutant TAFIIs were generated by Kodak) or glutathione beads were incubated with 35S-methionine-
inserting a 1.7 kb or 1.2 kb NdeI–BamHI fragment encoding TAFII labeled proteins generated using the TNT coupled in vitro transcrip-
110DC and TAFII110DB, respectively, or a 1.8 kb NdeI–BamHI frag- tion/translation system (Promega). Protein complexes were pro-
ment encoding TAFII60YY into the corresponding restriction sites of cessed and bound proteins detected as previously described (Sauer
pSLFlag (Sauer et al., 1995b). Plasmids expressing GST-A, GST-Q, et al., 1995b).
or GST-QA, or B-A, B-Q, and the reporter plasmid phbCAT-298,
were described in Sauer et al. (1995b). In vitro transcription plasmids
Purification of TFIID from Embryosfor TAFII110, TAFII60, TAFII30a, and TFIIA-L have been described
Drosophila nuclear extracts were prepared as described by Biggin(Verrijzer and Tjian, 1996; Yokomori et al., 1993). Plasmids for in
and Tjian (1988) and applied onto a heparin column, and the 0.4 Mvitro transcription of mutant TAFs were generated by cloning cDNAs
HEMG eluate was used for the immunopurification of TFIID. Anti-for TAFII110DC or TAFII110DB as NdeI–XbaI, or for TAFII60YY as
body resin containing monoclonal TAFII250 antibody (2B2). ResinNdeI–BamHI fragment into pTbSTOP.
was incubated with 500 mg 0.4 eluate for 12 hr at 48C, washed withTo express TAFs under control of the bcd transcription unit, a
1 M HEMG–NP, and supe and resin were resolved by SDS–PAGE.125 bp BglII–NdeI fragment containing the b-globin leader and the
Proteins were transferred onto nitrocellulose and TAFII110, and de-hemaglutinin epitope tag was inserted into pAR110 to generate
rivatives were detected using a polyclonal TAFII110 antibodypGHA110. A 850 bp EcoRV–XbaI fragment containing the bcd 39UTR
(1:10000 dilution).was cloned into pBluescriptBglII (F. S., unpublished data), con-
taining a BglII at the position of the XhoI site, to generate pB39UTR.
To generate TAFII110 /bcd 39UTR a 2.1 kb BglII- XbaI (blunt end ), Drosophila Strains and Transgenic Lines
Drosophila stocks were raised under standard conditions. The hba 1.75 BglII- BamHI (blunt end), 1.2 kb BglII- XmnI fragments derived
from pGHA110 were cloned into the BglII–EcoRV restriction sites stock Df(3R)p-XT103 has been described by Lehmann and Nu¨sslein-
Volhard (1987); the hkb stock hkbXM9, by Bro¨nner et al. (1995). Theof pB39UTR to generate pGHA-110UTR, pGHA-110DCUTR, or
pGHA2110DBUTR, respectively. Fusion genes were inserted as receptor strain for P-element plasmids w1118 was injected with DNA
at a concentration of 1.0 mg/ml with 100 mg/ml helper plasmidBglII–XbaI into pC-bcd, a pCaSpeR derivative containing a 2.2 kb
BamHI–PstI bcd enhancer/promoter fragment (Driever et al., 1990) (Karess and Rubin, 1984). For each construct, four independent
lines were established. The chromosomal location of the P elementsto generate pC-bcd-110UTR, pC-bcd-110DCUTR, or pC-bcd-
110DBUTR. P-element plasmids expressing Gal4/Bicoid fusion pro- was determined by crossing the transgenic lines with balanced
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Isolation of Genomic DNA for TAFII60 and TAFII110 of this work. We thank Marlein Jeans for injections; Noah Solomon
for DNA sequencing of TAFII alleles; Todd Laverty for cytologicaland cDNAs for TAFII110
The TAFII110 locus was recovered from a P1-phage clone (P1 38–46) characterization of TAFII alleles; Doug Davis, Tanya Wolff, and Marc
Therrien for assistance with the scanning electron microscopy; Ilariathat was mapped to the 72D chromosomal region by the Berkeley
Drosophila Genome Project (G. M. R., personal communication). A Rebay, Tom Neufeld, Jim Kennison, Martin Zeidler, Marek Mlodzik,
and Peter Verrijzer for communicating unpublished data and/or for12 kb BamHI fragment from this clone spans the inversion
breakpoint within the TAFII110XS-2884 allele and was used to screen providing fly stocks; and Christiane Nu¨sslein-Volhard, Wolfgang
Driever, Timothy Hoey, Pierre Beaurang, Catherine Thut, and Ernsta Drosophila melanogaster eye-imaginal disc cDNA library in lgt10
(A. Cowman, unpublished data). TAFII110 genomic DNA, contained Wimmer for contributing fly strains, plasmids, or antibodies. The
manuscript was improved by valuable comments from Paul Wade,within adjacent 12 kb and 5 kb BamHI fragments, from S-466 and
XS-793 was cloned into Lambda Fix II or ZAP express vectors (Stra- Marc Therrien, Thomas Cline, Donald Rio, Timothy Hoey, Richard
Losick, Mike Levine, Donald Rio, and Steve McKnight. D. A. W. wastagene). The entire TAFII110 coding region was sequenced on both
strands by the dideoxy chain termination procedure using the auto- supported by a Helen Hay Whitney fellowship. F. S. is supported
by a fellowship from the Max-Planck Gesellschaft (Otto Hahn Prize).mated laser fluorescence (ALF) system (Pharmacia). Sequences
were analyzed using Staden and Genetics Computer Group (GCG) This work was supported, in part, by a National Institute of Health
grant (R. T.).software packages.
TAFII60 genomic DNA, contained within a 5.5 kb EcoRI fragment,
Received November 7, 1996; revised November 13, 1996.from XS-922 was cloned into the ZAP express vector (Stratagene)
and sequenced and analyzed as described above.
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